» Articles » PMID: 35504878

High-throughput Single-сell Sequencing in Cancer Research

Overview
Date 2022 May 3
PMID 35504878
Authors
Affiliations
Soon will be listed here.
Abstract

With advances in sequencing and instrument technology, bioinformatics analysis is being applied to batches of massive cells at single-cell resolution. High-throughput single-cell sequencing can be utilized for multi-omics characterization of tumor cells, stromal cells or infiltrated immune cells to evaluate tumor progression, responses to environmental perturbations, heterogeneous composition of the tumor microenvironment, and complex intercellular interactions between these factors. Particularly, single-cell sequencing of T cell receptors, alone or in combination with single-cell RNA sequencing, is useful in the fields of tumor immunology and immunotherapy. Clinical insights obtained from single-cell analysis are critically important for exploring the biomarkers of disease progression or antitumor treatment, as well as for guiding precise clinical decision-making for patients with malignant tumors. In this review, we summarize the clinical applications of single-cell sequencing in the fields of tumor cell evolution, tumor immunology, and tumor immunotherapy. Additionally, we analyze the tumor cell response to antitumor treatment, heterogeneity of the tumor microenvironment, and response or resistance to immune checkpoint immunotherapy. The limitations of single-cell analysis in cancer research are also discussed.

Citing Articles

Analysis of single-cell and spatial transcriptomics in TNBC cell-cell interactions.

Xin Y, Ma Q, Deng Q, Wang T, Wang D, Wang G Front Immunol. 2025; 16:1521388.

PMID: 40079015 PMC: 11897037. DOI: 10.3389/fimmu.2025.1521388.


Single-Cell RNA Sequencing in Unraveling Acquired Resistance to EGFR-TKIs in Non-Small Cell Lung Cancer: New Perspectives.

Peng L, Deng S, Li J, Zhang Y, Zhang L Int J Mol Sci. 2025; 26(4).

PMID: 40003951 PMC: 11855476. DOI: 10.3390/ijms26041483.


Tumor-infiltrating myeloid cells; mechanisms, functional significance, and targeting in cancer therapy.

Toghraie F, Bayat M, Hosseini M, Ramezani A Cell Oncol (Dordr). 2025; .

PMID: 39998754 DOI: 10.1007/s13402-025-01051-y.


Immunotherapy-induced microsatellite instability status shift in recurrent perihilar cholangiocarcinoma: A case report.

Yu H, Deng T, Liu H Hum Vaccin Immunother. 2025; 21(1):2471226.

PMID: 39996476 PMC: 11864312. DOI: 10.1080/21645515.2025.2471226.


Integrating single-cell sequencing and machine learning to uncover the role of mitophagy in subtyping and prognosis of esophageal cancer.

Tian F, He X, Wang S, Liang Y, Wang Z, Hu M Apoptosis. 2025; .

PMID: 39948301 DOI: 10.1007/s10495-024-02061-1.


References
1.
Jia Q, Wu W, Wang Y, Alexander P, Sun C, Gong Z . Local mutational diversity drives intratumoral immune heterogeneity in non-small cell lung cancer. Nat Commun. 2018; 9(1):5361. PMC: 6299138. DOI: 10.1038/s41467-018-07767-w. View

2.
Pilkington E, Suys E, Trevaskis N, Wheatley A, Zukancic D, Algarni A . From influenza to COVID-19: Lipid nanoparticle mRNA vaccines at the frontiers of infectious diseases. Acta Biomater. 2021; 131:16-40. PMC: 8272596. DOI: 10.1016/j.actbio.2021.06.023. View

3.
Gerlinger M, Rowan A, Horswell S, Math M, Larkin J, Endesfelder D . Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med. 2012; 366(10):883-892. PMC: 4878653. DOI: 10.1056/NEJMoa1113205. View

4.
Cavalli F, Remke M, Rampasek L, Peacock J, Shih D, Luu B . Intertumoral Heterogeneity within Medulloblastoma Subgroups. Cancer Cell. 2017; 31(6):737-754.e6. PMC: 6163053. DOI: 10.1016/j.ccell.2017.05.005. View

5.
Navin N, Hicks J . Future medical applications of single-cell sequencing in cancer. Genome Med. 2011; 3(5):31. PMC: 3219072. DOI: 10.1186/gm247. View